South Dakota Investment Council’s Bio-Rad Laboratories Class A BIO Stock Holding History

South Dakota Investment Council’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-40	Closed	-$30K	–	588
2021 Q3	$30K	Sell	40 -600	-94%	-$449K	﹤0.01%	581
2021 Q2	$412K	Sell	640 -140	-18%	-$85.2K	0.01%	543
2021 Q1	$446K	Sell	780 -300	-28%	-$178K	0.01%	557
2020 Q4	$630K	Sell	1,080 -600	-36%	-$342K	0.01%	501
2020 Q3	$866K	Sell	1,680 -1,100	-40%	-$557K	0.02%	434
2020 Q2	$1.25M	Buy	2,780 +780	+39%	+$344K	0.03%	360
2020 Q1	$701K	Hold	2,000	–	–	0.02%	412
2019 Q4	$740K	Hold	2,000	–	–	0.02%	448
2019 Q3	$665K	Buy	2,000 +900	+82%	+$294K	0.01%	492
2019 Q2	$344K	Hold	1,100	–	–	0.01%	535
2019 Q1	$336K	Buy	1,100 +600	+120%	+$162K	0.01%	529
2018 Q4	$116K	Buy	+500	New	+$134K	﹤0.01%	588

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

South Dakota Investment Council's BIO Position: Q4 2021 in Review

South Dakota Investment Council sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2021, closing a stake of 40 shares — an estimated $30K sold.

South Dakota Investment Council first reported a position in BIO in Q4 2018 and held it in 12 quarters. The position peaked at $1.25M in Q2 2020. 534 funds tracked by Wall St. Rank hold BIO as of Q4 2021.

South Dakota Investment Council reported no remaining Bio-Rad Laboratories Class A position as of Q4 2021 after selling out during the quarter.
South Dakota Investment Council sold 40 Bio-Rad Laboratories Class A shares in Q4 2021, an estimated $30K.
South Dakota Investment Council first reported a position in Bio-Rad Laboratories Class A in Q4 2018 and held it in 12 quarters.
South Dakota Investment Council's Bio-Rad Laboratories Class A position peaked at $1.25M in Q2 2020.
534 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2021.

Based on South Dakota Investment Council's 13F filing for Q4 2021, filed 8 Feb 2022.